Agilent Technologies Inc. (A)
Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock?
A's shares ride on the bright performance of the Agilent CrossLab Group segment and strategic acquisitions.
International Markets and Agilent (A): A Deep Dive for Investors
Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Agilent Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
A's fourth-quarter 2024 results benefit from strong demand in the ACG segment. However, declining sales in the Americas and China markets raise concerns.
Agilent Q4: Expecting Market Recovery In 2025
I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic growth and market recovery. Agilent's acquisition of BIOVECTRA will enhance its CDMO business, focusing on oligonucleotides and CRISPR therapeutics, and expand service offerings in peptide synthesis. Agilent's FY25 guidance includes 2.5%-3.5% core revenue growth and 5.8% adjusted EPS growth, aligned with market expectations and supported by segment-specific growth strategies.
Agilent Technologies, Inc. (A) Q4 2024 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q4 2024 Results Conference Call November 25, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Vice President, Investor Relations Padraig McDonnell - President and CEO Bob McMahon - Senior Vice President and CFO Simon May - President, Life Sciences and Diagnostic Markets Group Phil Binns - President, Life Sciences & Applied Markets Group Angelica Riemann - President, Agilent CrossLab Group Mike Zhang - President, Applied Markets Group Conference Call Participants Patrick Donnelly - Citi Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Vijay Kumar - Evercore ISI Jack Meehan - Nephron Research Dan Leonard - UBS Puneet Souda - Leerink Partners Tycho Peterson - Jefferies Brandon Couillard - Wells Fargo Doug Schenkel - Wolfe Research Michael Ryskin - Bank of America Dan Brennan - TD Cowen Operator Good afternoon. My name is Rob, and I will be your conference operator today.
Agilent (A) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended October 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agilent Technologies (A) Beats Q4 Earnings and Revenue Estimates
Agilent Technologies (A) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.41 per share. This compares to earnings of $1.38 per share a year ago.
Medical equipment maker Agilent's downbeat annual forecast clouds fourth-quarter beat
Agilent forecast its annual profit below analysts' estimates on Monday, as a recovery is ongoing in the market for medical tools and equipment used in clinical studies, sending its shares down more than 2% after the bell.
Agilent Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Agilent Technologies, Inc. A will release earnings results for the fourth quarter, after the closing bell on Monday, Nov. 25.
Agilent to Report Q4 Earnings: What's in the Cards for the Stock?
A's fourth-quarter performance is expected to have benefited from the growing ACG segment. However, falling end-market and regional sales raise concerns.
How To Earn $500 A Month From Agilent Stock Ahead Of Q4 Earnings
Agilent Technologies, Inc. A will release earnings results for the fourth quarter, after the closing bell, on Monday, Nov. 25.
What to Expect from Agilent's Quarterly Report
Agilent Technologies Inc (NYSE:A) is scheduled to release fourth-quarter financial results after the close on Monday, Nov. 25.
